Neostigmine recalls

The FDA has published 2 recalls involving Neostigmine since 2015. The latest was reported on 9 Aug 2023. Most were for sterility. Central Admixture Pharmacy Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 9 Aug 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why neostigmine is recalled

Sterility2100%

Companies

Central Admixture Pharmacy Services150%
US Compounding150%

By year

2023150%
2015150%

All neostigmine recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
9 Aug 2023Drug	CLASS II	neostigmine 5 mg/ (1mg/mL) Syringe recalled	Central Admixture Pharmacy Services	Sterility	Nationwide
25 Nov 2015Drug	CLASS II	Neostigmine (5 mg/ Single Use Syringe, For IM recalled by US Compounding	US Compounding	Sterility	Nationwide

Should you stop taking Neostigmine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.